Ketamine Infusions for Chronic Pain Are Widely Used, but Guidelines Are Scarce

Ketamine Infusions for Chronic Pain Are Widely Used, but Guidelines Are Scarce

By Ivan Urits, MD – Board Certified in Anesthesiology and Pain Medicine

Published August 25, 2026 | Category: Pain Medicine

Off-label ketamine infusions are used for chronic non-cancer pain, including nerve pain, central sensitization and opioid tapering. Treatment regimens, doses and monitoring vary widely from clinic to clinic. A 2026 scoping review in Anaesthesia and Intensive Care asked whether clear treatment guidelines now exist.

This summary is based on the published abstract. Read the abstract on PubMed

What the authors did

The authors searched major medical databases for publications on ketamine infusion guidelines or protocols for chronic pain, excluding acute pain, cancer pain and children. They examined 42 publications and evaluated any guidelines found against Australia's National Health and Medical Research Council (NHMRC) standards for guideline quality.

What they found

  • Only three publications qualified as guidelines.
  • These met between 34% and 76% of the NHMRC quality standards.
  • No published Australian guideline exists for ketamine in chronic non-cancer pain, despite ongoing use.

The authors conclude that an established guideline, possibly developed through expert consensus, is needed so that the effectiveness and side effects of ketamine can be measured against a consistent standard.

Why this matters

Ketamine can cause hallucinations, high blood pressure, fast heart rate and, with repeated use, bladder and liver problems. Without guidelines, practices may differ in patient selection, dosing, monitoring and follow-up, which makes it harder to keep patients safe and to judge whether treatment works.

Limitations

This review evaluated the existence and quality of guidelines, not ketamine's effectiveness or safety. The search was limited to English-language publications up to May 2024.

Safety takeaways: how to apply it

For pain physicians and procedure teams

  • Use a written local protocol for ketamine infusions covering patient selection, dosing, monitoring, discharge criteria and follow-up.
  • Screen for conditions that raise risk, such as uncontrolled high blood pressure, psychosis or substance misuse.
  • Track side effects and outcomes over repeated treatments.

For hospitals, clinics and safety leaders

  • Base ketamine programs on available society guidance, and audit them regularly.

For patients and families

  • Ask how your ketamine treatment is monitored and what side effects to watch for.

Reference

  1. Daff MLM, Eblen SA, Somogyi AA, Rough KV, Hollington IB. A scoping review for published guidelines for use of ketamine in chronic non-cancer pain. Anaesth Intensive Care. Published online 2026 Jul 30. doi:10.1177/0310057X261460082. PMID: 42533509. PubMed: https://pubmed.ncbi.nlm.nih.gov/42533509/

This article is educational information, not legal or medical advice.

Previous
Previous

Epidural Hematoma After Spine Procedures: Act on Pain, Don’t Wait for Weakness

Next
Next

What to Do If a Spine Injection Goes Into an Artery